Studying	B:C0681814
neuroprotective	O
effect	O
of	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
drug	O
on	O
high	O
glucose	I:C0860803
-	O
induced	O
neurotoxicity	O
in	O
undifferentiated	O
PC12	O
cells	I:C0085262
:	O
role	O
of	O
NADPH	O
oxidase	I:C0068355
.	O

Studying	O
neuroprotective	O
effect	O
of	O
Atorvastatin	B:C0286651
as	O
a	O
small	O
molecule	I:C1328819
drug	O
on	O
high	O
glucose	I:C0860803
-	O
induced	O
neurotoxicity	O
in	O
undifferentiated	O
PC12	O
cells	I:C0085262
:	O
role	O
of	O
NADPH	O
oxidase	I:C0068355
.	O

Studying	O
neuroprotective	O
effect	O
of	O
Atorvastatin	O
as	O
a	O
small	B:C1328819
molecule	I:C1328819
drug	O
on	O
high	O
glucose	I:C0860803
-	O
induced	O
neurotoxicity	O
in	O
undifferentiated	O
PC12	O
cells	I:C0085262
:	O
role	O
of	O
NADPH	O
oxidase	I:C0068355
.	O

Studying	O
neuroprotective	O
effect	O
of	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
drug	B:C1254351
on	O
high	O
glucose	I:C0860803
-	O
induced	O
neurotoxicity	O
in	O
undifferentiated	O
PC12	O
cells	I:C0085262
:	O
role	O
of	O
NADPH	O
oxidase	I:C0068355
.	O

Studying	O
neuroprotective	O
effect	O
of	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
drug	O
on	O
high	B:C0860803
glucose	I:C0860803
-	O
induced	O
neurotoxicity	O
in	O
undifferentiated	O
PC12	O
cells	I:C0085262
:	O
role	O
of	O
NADPH	O
oxidase	I:C0068355
.	O

Studying	O
neuroprotective	O
effect	O
of	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
drug	O
on	O
high	O
glucose	I:C0860803
-	O
induced	O
neurotoxicity	B:C0235032
in	O
undifferentiated	O
PC12	O
cells	I:C0085262
:	O
role	O
of	O
NADPH	O
oxidase	I:C0068355
.	O

Studying	O
neuroprotective	O
effect	O
of	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
drug	O
on	O
high	O
glucose	I:C0860803
-	O
induced	O
neurotoxicity	O
in	O
undifferentiated	O
PC12	B:C0085262
cells	I:C0085262
:	O
role	O
of	O
NADPH	O
oxidase	I:C0068355
.	O

Studying	O
neuroprotective	O
effect	O
of	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
drug	O
on	O
high	O
glucose	I:C0860803
-	O
induced	O
neurotoxicity	O
in	O
undifferentiated	O
PC12	O
cells	I:C0085262
:	O
role	O
of	O
NADPH	B:C0068355
oxidase	I:C0068355
.	O

Overproduction	O
of	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
by	O
NADPH	O
oxidase	I:C0068355
(	O
NADPH	O
oxidase	I:C0068355
)	O
activation	O
has	O
been	O
considered	O
the	O
essential	O
mechanism	O
induced	O
by	O
hyperglycemia	O
in	O
various	O
tissues	O
.	O

Overproduction	O
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
)	O
by	O
NADPH	O
oxidase	I:C0068355
(	O
NADPH	O
oxidase	I:C0068355
)	O
activation	O
has	O
been	O
considered	O
the	O
essential	O
mechanism	O
induced	O
by	O
hyperglycemia	O
in	O
various	O
tissues	O
.	O

Overproduction	O
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
by	O
NADPH	B:C0068355
oxidase	I:C0068355
(	O
NADPH	O
oxidase	I:C0068355
)	O
activation	O
has	O
been	O
considered	O
the	O
essential	O
mechanism	O
induced	O
by	O
hyperglycemia	O
in	O
various	O
tissues	O
.	O

Overproduction	O
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
by	O
NADPH	O
oxidase	I:C0068355
(	O
NADPH	B:C0068355
oxidase	I:C0068355
)	O
activation	O
has	O
been	O
considered	O
the	O
essential	O
mechanism	O
induced	O
by	O
hyperglycemia	O
in	O
various	O
tissues	O
.	O

Overproduction	O
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
by	O
NADPH	O
oxidase	I:C0068355
(	O
NADPH	O
oxidase	I:C0068355
)	O
activation	B:C0014429
has	O
been	O
considered	O
the	O
essential	O
mechanism	O
induced	O
by	O
hyperglycemia	O
in	O
various	O
tissues	O
.	O

Overproduction	O
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
by	O
NADPH	O
oxidase	I:C0068355
(	O
NADPH	O
oxidase	I:C0068355
)	O
activation	O
has	O
been	O
considered	O
the	O
essential	O
mechanism	O
induced	O
by	O
hyperglycemia	B:C0020456
in	O
various	O
tissues	O
.	O

Overproduction	O
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
by	O
NADPH	O
oxidase	I:C0068355
(	O
NADPH	O
oxidase	I:C0068355
)	O
activation	O
has	O
been	O
considered	O
the	O
essential	O
mechanism	O
induced	O
by	O
hyperglycemia	O
in	O
various	O
tissues	B:C0040300
.	O

However	O
,	O
there	O
is	O
no	O
comprehensive	O
study	B:C0681814
on	O
the	O
role	O
of	O
NOXs	O
in	O
high	O
glucose	I:C0860803
(	O
high	O
glucose	I:C0860803
)	O
-	O
induced	O
toxic	O
effect	I:C0600688
in	O
neural	O
tissues	I:C0027757
.	O

However	O
,	O
there	O
is	O
no	O
comprehensive	O
study	O
on	O
the	O
role	O
of	O
NOXs	B:C0068355
in	O
high	O
glucose	I:C0860803
(	O
high	O
glucose	I:C0860803
)	O
-	O
induced	O
toxic	O
effect	I:C0600688
in	O
neural	O
tissues	I:C0027757
.	O

However	O
,	O
there	O
is	O
no	O
comprehensive	O
study	O
on	O
the	O
role	O
of	O
NOXs	O
in	O
high	B:C0860803
glucose	I:C0860803
(	O
high	O
glucose	I:C0860803
)	O
-	O
induced	O
toxic	O
effect	I:C0600688
in	O
neural	O
tissues	I:C0027757
.	O

However	O
,	O
there	O
is	O
no	O
comprehensive	O
study	O
on	O
the	O
role	O
of	O
NOXs	O
in	O
high	O
glucose	I:C0860803
(	O
high	B:C0860803
glucose	I:C0860803
)	O
-	O
induced	O
toxic	O
effect	I:C0600688
in	O
neural	O
tissues	I:C0027757
.	O

However	O
,	O
there	O
is	O
no	O
comprehensive	O
study	O
on	O
the	O
role	O
of	O
NOXs	O
in	O
high	O
glucose	I:C0860803
(	O
high	O
glucose	I:C0860803
)	O
-	O
induced	O
toxic	B:C0600688
effect	I:C0600688
in	O
neural	O
tissues	I:C0027757
.	O

However	O
,	O
there	O
is	O
no	O
comprehensive	O
study	O
on	O
the	O
role	O
of	O
NOXs	O
in	O
high	O
glucose	I:C0860803
(	O
high	O
glucose	I:C0860803
)	O
-	O
induced	O
toxic	O
effect	I:C0600688
in	O
neural	B:C0027757
tissues	I:C0027757
.	O

Recently	O
,	O
a	O
therapeutic	O
strategy	O
in	O
oxidative	O
related	O
pathologies	B:C0030664
has	O
been	O
introduced	O
by	O
blocking	O
the	O
undesirable	O
actions	O
of	O
NOX	O
enzymes	I:C0068355
by	O
small	O
molecules	I:C1328819
.	O

Recently	O
,	O
a	O
therapeutic	O
strategy	O
in	O
oxidative	O
related	O
pathologies	O
has	O
been	O
introduced	O
by	O
blocking	O
the	O
undesirable	O
actions	O
of	O
NOX	B:C0068355
enzymes	I:C0068355
by	O
small	O
molecules	I:C1328819
.	O

Recently	O
,	O
a	O
therapeutic	O
strategy	O
in	O
oxidative	O
related	O
pathologies	O
has	O
been	O
introduced	O
by	O
blocking	O
the	O
undesirable	O
actions	O
of	O
NOX	O
enzymes	I:C0068355
by	O
small	B:C1328819
molecules	I:C1328819
.	O

The	O
protective	O
roles	O
of	O
Statins	B:C0360714
in	O
ameliorating	O
oxidative	O
stress	I:C0242606
by	O
NADPH	O
oxidase	I:C0068355
inhibition	O
have	O
been	O
shown	O
in	O
some	O
tissues	O
except	O
neural	O
.	O

The	O
protective	O
roles	O
of	O
Statins	O
in	O
ameliorating	O
oxidative	B:C0242606
stress	I:C0242606
by	O
NADPH	O
oxidase	I:C0068355
inhibition	O
have	O
been	O
shown	O
in	O
some	O
tissues	O
except	O
neural	O
.	O

The	O
protective	O
roles	O
of	O
Statins	O
in	O
ameliorating	O
oxidative	O
stress	I:C0242606
by	O
NADPH	B:C0068355
oxidase	I:C0068355
inhibition	O
have	O
been	O
shown	O
in	O
some	O
tissues	O
except	O
neural	O
.	O

The	O
protective	O
roles	O
of	O
Statins	O
in	O
ameliorating	O
oxidative	O
stress	I:C0242606
by	O
NADPH	O
oxidase	I:C0068355
inhibition	B:C1524081
have	O
been	O
shown	O
in	O
some	O
tissues	O
except	O
neural	O
.	O

The	O
protective	O
roles	O
of	O
Statins	O
in	O
ameliorating	O
oxidative	O
stress	I:C0242606
by	O
NADPH	O
oxidase	I:C0068355
inhibition	O
have	O
been	O
shown	O
in	O
some	O
tissues	B:C0040300
except	O
neural	O
.	O

The	O
protective	O
roles	O
of	O
Statins	O
in	O
ameliorating	O
oxidative	O
stress	I:C0242606
by	O
NADPH	O
oxidase	I:C0068355
inhibition	O
have	O
been	O
shown	O
in	O
some	O
tissues	O
except	O
neural	B:C0027757
.	O

We	O
hypothesized	O
then	O
,	O
that	O
different	O
NOXs	B:C0068355
may	O
have	O
role	O
in	O
high	O
glucose	I:C0860803
-	O
induced	O
neural	O
cell	O
injury	O
.	O

We	O
hypothesized	O
then	O
,	O
that	O
different	O
NOXs	O
may	O
have	O
role	O
in	O
high	B:C0860803
glucose	I:C0860803
-	O
induced	O
neural	O
cell	O
injury	O
.	O

Furthermore	O
,	O
we	O
postulate	O
that	O
Atorvastatin	B:C0286651
as	O
a	O
small	O
molecule	I:C1328819
may	O
modulate	O
this	O
NOXs	O
activity	I:C1151146
to	O
protect	O
neural	O
cells	I:C0027882
.	O

Furthermore	O
,	O
we	O
postulate	O
that	O
Atorvastatin	O
as	O
a	O
small	B:C1328819
molecule	I:C1328819
may	O
modulate	O
this	O
NOXs	O
activity	I:C1151146
to	O
protect	O
neural	O
cells	I:C0027882
.	O

Furthermore	O
,	O
we	O
postulate	O
that	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
may	O
modulate	B:C0443264
this	O
NOXs	O
activity	I:C1151146
to	O
protect	O
neural	O
cells	I:C0027882
.	O

Furthermore	O
,	O
we	O
postulate	O
that	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
may	O
modulate	O
this	O
NOXs	B:C1151146
activity	I:C1151146
to	O
protect	O
neural	O
cells	I:C0027882
.	O

Furthermore	O
,	O
we	O
postulate	O
that	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
may	O
modulate	O
this	O
NOXs	O
activity	I:C1151146
to	O
protect	O
neural	B:C0027882
cells	I:C0027882
.	O

Undifferentiated	O
PC12	B:C0085262
cells	I:C0085262
were	O
treated	O
with	I:C0332293
high	O
glucose	I:C0860803
(	O
140	O
mM	O
/	O
24	O
h	O
)	O
in	O
the	O
presence	O
and	O
absence	O
of	O
Atorvastatin	O
(	O
1	O
μM	O
/	O
96	O
h	O
)	O
.	O

Undifferentiated	O
PC12	O
cells	I:C0085262
were	O
treated	B:C0332293
with	I:C0332293
high	O
glucose	I:C0860803
(	O
140	O
mM	O
/	O
24	O
h	O
)	O
in	O
the	O
presence	O
and	O
absence	O
of	O
Atorvastatin	O
(	O
1	O
μM	O
/	O
96	O
h	O
)	O
.	O

Undifferentiated	O
PC12	O
cells	I:C0085262
were	O
treated	O
with	I:C0332293
high	B:C0860803
glucose	I:C0860803
(	O
140	O
mM	O
/	O
24	O
h	O
)	O
in	O
the	O
presence	O
and	O
absence	O
of	O
Atorvastatin	O
(	O
1	O
μM	O
/	O
96	O
h	O
)	O
.	O

Undifferentiated	O
PC12	O
cells	I:C0085262
were	O
treated	O
with	I:C0332293
high	O
glucose	I:C0860803
(	O
140	O
mM	O
/	O
24	O
h	O
)	O
in	O
the	O
presence	B:C0150312
and	O
absence	O
of	O
Atorvastatin	O
(	O
1	O
μM	O
/	O
96	O
h	O
)	O
.	O

Undifferentiated	O
PC12	O
cells	I:C0085262
were	O
treated	O
with	I:C0332293
high	O
glucose	I:C0860803
(	O
140	O
mM	O
/	O
24	O
h	O
)	O
in	O
the	O
presence	O
and	O
absence	O
of	O
Atorvastatin	B:C0286651
(	O
1	O
μM	O
/	O
96	O
h	O
)	O
.	O

The	O
cell	B:C0007620
viability	I:C0007620
was	O
measured	O
by	O
MTT	O
assay	I:C2986858
and	O
the	O
gene	O
and	O
protein	O
expressions	I:C3463810
profile	I:C3463810
of	O
NADPH	O
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
were	O
determined	O
by	O
RT	O
-	I:C0599161
PCR	I:C0599161
and	O
western	O
blotting	I:C0005863
,	O
respectively	O
.	O

The	O
cell	O
viability	I:C0007620
was	O
measured	O
by	O
MTT	B:C2986858
assay	I:C2986858
and	O
the	O
gene	O
and	O
protein	O
expressions	I:C3463810
profile	I:C3463810
of	O
NADPH	O
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
were	O
determined	O
by	O
RT	O
-	I:C0599161
PCR	I:C0599161
and	O
western	O
blotting	I:C0005863
,	O
respectively	O
.	O

The	O
cell	O
viability	I:C0007620
was	O
measured	O
by	O
MTT	O
assay	I:C2986858
and	O
the	O
gene	O
and	O
protein	B:C3463810
expressions	I:C3463810
profile	I:C3463810
of	O
NADPH	O
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
were	O
determined	O
by	O
RT	O
-	I:C0599161
PCR	I:C0599161
and	O
western	O
blotting	I:C0005863
,	O
respectively	O
.	O

The	O
cell	O
viability	I:C0007620
was	O
measured	O
by	O
MTT	O
assay	I:C2986858
and	O
the	O
gene	O
and	O
protein	O
expressions	I:C3463810
profile	I:C3463810
of	O
NADPH	B:C0068355
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
were	O
determined	O
by	O
RT	O
-	I:C0599161
PCR	I:C0599161
and	O
western	O
blotting	I:C0005863
,	O
respectively	O
.	O

The	O
cell	O
viability	I:C0007620
was	O
measured	O
by	O
MTT	O
assay	I:C2986858
and	O
the	O
gene	O
and	O
protein	O
expressions	I:C3463810
profile	I:C3463810
of	O
NADPH	O
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
were	O
determined	O
by	O
RT	B:C0599161
-	I:C0599161
PCR	I:C0599161
and	O
western	O
blotting	I:C0005863
,	O
respectively	O
.	O

The	O
cell	O
viability	I:C0007620
was	O
measured	O
by	O
MTT	O
assay	I:C2986858
and	O
the	O
gene	O
and	O
protein	O
expressions	I:C3463810
profile	I:C3463810
of	O
NADPH	O
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
were	O
determined	O
by	O
RT	O
-	I:C0599161
PCR	I:C0599161
and	O
western	B:C0005863
blotting	I:C0005863
,	O
respectively	O
.	O

Levels	O
of	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
(	O
malondialdehyde	O
)	O
were	O
also	O
evaluated	O
.	O

Levels	O
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	B:C0024643
(	O
malondialdehyde	O
)	O
were	O
also	O
evaluated	O
.	O

Levels	O
of	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
(	O
malondialdehyde	B:C0024643
)	O
were	O
also	O
evaluated	O
.	O

Gene	B:C0017262
and	O
protein	O
expression	I:C1171362
levels	O
of	O
NADPH	O
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
and	O
consequently	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
were	O
elevated	O
in	O
high	O
glucose	I:C0860803
-	O
treated	O
PC12	O
cells	I:C0085262
.	O

Gene	O
and	O
protein	B:C1171362
expression	I:C1171362
levels	O
of	O
NADPH	O
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
and	O
consequently	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
were	O
elevated	O
in	O
high	O
glucose	I:C0860803
-	O
treated	O
PC12	O
cells	I:C0085262
.	O

Gene	O
and	O
protein	O
expression	I:C1171362
levels	O
of	O
NADPH	B:C0068355
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
and	O
consequently	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
were	O
elevated	O
in	O
high	O
glucose	I:C0860803
-	O
treated	O
PC12	O
cells	I:C0085262
.	O

Gene	O
and	O
protein	O
expression	I:C1171362
levels	O
of	O
NADPH	O
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
and	O
consequently	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
were	O
elevated	O
in	O
high	O
glucose	I:C0860803
-	O
treated	O
PC12	O
cells	I:C0085262
.	O

Gene	O
and	O
protein	O
expression	I:C1171362
levels	O
of	O
NADPH	O
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
and	O
consequently	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	B:C0024643
levels	O
were	O
elevated	O
in	O
high	O
glucose	I:C0860803
-	O
treated	O
PC12	O
cells	I:C0085262
.	O

Gene	O
and	O
protein	O
expression	I:C1171362
levels	O
of	O
NADPH	O
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
and	O
consequently	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
were	O
elevated	O
in	O
high	B:C0860803
glucose	I:C0860803
-	O
treated	O
PC12	O
cells	I:C0085262
.	O

Gene	O
and	O
protein	O
expression	I:C1171362
levels	O
of	O
NADPH	O
oxidase	I:C0068355
(	O
1	O
-	O
4	O
)	O
and	O
consequently	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
were	O
elevated	O
in	O
high	O
glucose	I:C0860803
-	O
treated	O
PC12	B:C0085262
cells	I:C0085262
.	O

Atorvastatin	B:C0286651
could	O
significantly	O
decrease	O
high	O
glucose	I:C0860803
-	O
induced	O
NOXs	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
elevation	O
and	O
improve	O
impaired	O
cell	O
viability	I:C0007620
.	O

Atorvastatin	O
could	O
significantly	O
decrease	O
high	B:C0860803
glucose	I:C0860803
-	O
induced	O
NOXs	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
elevation	O
and	O
improve	O
impaired	O
cell	O
viability	I:C0007620
.	O

Atorvastatin	O
could	O
significantly	O
decrease	O
high	O
glucose	I:C0860803
-	O
induced	O
NOXs	B:C0068355
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
elevation	O
and	O
improve	O
impaired	O
cell	O
viability	I:C0007620
.	O

Atorvastatin	O
could	O
significantly	O
decrease	O
high	O
glucose	I:C0860803
-	O
induced	O
NOXs	O
,	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
elevation	O
and	O
improve	O
impaired	O
cell	O
viability	I:C0007620
.	O

Atorvastatin	O
could	O
significantly	O
decrease	O
high	O
glucose	I:C0860803
-	O
induced	O
NOXs	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	B:C0024643
elevation	O
and	O
improve	O
impaired	O
cell	O
viability	I:C0007620
.	O

Atorvastatin	O
could	O
significantly	O
decrease	O
high	O
glucose	I:C0860803
-	O
induced	O
NOXs	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
elevation	B:C0702240
and	O
improve	O
impaired	O
cell	O
viability	I:C0007620
.	O

Atorvastatin	O
could	O
significantly	O
decrease	O
high	O
glucose	I:C0860803
-	O
induced	O
NOXs	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
elevation	O
and	O
improve	B:C0184511
impaired	O
cell	O
viability	I:C0007620
.	O

Atorvastatin	O
could	O
significantly	O
decrease	O
high	O
glucose	I:C0860803
-	O
induced	O
NOXs	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
elevation	O
and	O
improve	O
impaired	O
cell	B:C0007620
viability	I:C0007620
.	O

It	O
can	O
be	O
concluded	O
that	O
high	B:C0860803
glucose	I:C0860803
could	O
elevate	O
NOXs	O
activity	I:C1151146
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
in	O
neural	O
tissues	I:C0027757
and	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
NOX	O
inhibitor	I:C1254351
drug	I:C1254351
may	O
prevent	O
and	O
delay	O
diabetic	O
complications	I:C0342257
,	O
particularly	O
neuropathy	O
.	O

It	O
can	O
be	O
concluded	O
that	O
high	O
glucose	I:C0860803
could	O
elevate	O
NOXs	B:C1151146
activity	I:C1151146
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
in	O
neural	O
tissues	I:C0027757
and	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
NOX	O
inhibitor	I:C1254351
drug	I:C1254351
may	O
prevent	O
and	O
delay	O
diabetic	O
complications	I:C0342257
,	O
particularly	O
neuropathy	O
.	O

It	O
can	O
be	O
concluded	O
that	O
high	O
glucose	I:C0860803
could	O
elevate	O
NOXs	O
activity	I:C1151146
,	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
in	O
neural	O
tissues	I:C0027757
and	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
NOX	O
inhibitor	I:C1254351
drug	I:C1254351
may	O
prevent	O
and	O
delay	O
diabetic	O
complications	I:C0342257
,	O
particularly	O
neuropathy	O
.	O

It	O
can	O
be	O
concluded	O
that	O
high	O
glucose	I:C0860803
could	O
elevate	O
NOXs	O
activity	I:C1151146
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	B:C0024643
levels	O
in	O
neural	O
tissues	I:C0027757
and	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
NOX	O
inhibitor	I:C1254351
drug	I:C1254351
may	O
prevent	O
and	O
delay	O
diabetic	O
complications	I:C0342257
,	O
particularly	O
neuropathy	O
.	O

It	O
can	O
be	O
concluded	O
that	O
high	O
glucose	I:C0860803
could	O
elevate	O
NOXs	O
activity	I:C1151146
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
in	O
neural	B:C0027757
tissues	I:C0027757
and	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
NOX	O
inhibitor	I:C1254351
drug	I:C1254351
may	O
prevent	O
and	O
delay	O
diabetic	O
complications	I:C0342257
,	O
particularly	O
neuropathy	O
.	O

It	O
can	O
be	O
concluded	O
that	O
high	O
glucose	I:C0860803
could	O
elevate	O
NOXs	O
activity	I:C1151146
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
in	O
neural	O
tissues	I:C0027757
and	O
Atorvastatin	B:C0286651
as	O
a	O
small	O
molecule	I:C1328819
NOX	O
inhibitor	I:C1254351
drug	I:C1254351
may	O
prevent	O
and	O
delay	O
diabetic	O
complications	I:C0342257
,	O
particularly	O
neuropathy	O
.	O

It	O
can	O
be	O
concluded	O
that	O
high	O
glucose	I:C0860803
could	O
elevate	O
NOXs	O
activity	I:C1151146
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
in	O
neural	O
tissues	I:C0027757
and	O
Atorvastatin	O
as	O
a	O
small	B:C1328819
molecule	I:C1328819
NOX	O
inhibitor	I:C1254351
drug	I:C1254351
may	O
prevent	O
and	O
delay	O
diabetic	O
complications	I:C0342257
,	O
particularly	O
neuropathy	O
.	O

It	O
can	O
be	O
concluded	O
that	O
high	O
glucose	I:C0860803
could	O
elevate	O
NOXs	O
activity	I:C1151146
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
in	O
neural	O
tissues	I:C0027757
and	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
NOX	B:C1254351
inhibitor	I:C1254351
drug	I:C1254351
may	O
prevent	O
and	O
delay	O
diabetic	O
complications	I:C0342257
,	O
particularly	O
neuropathy	O
.	O

It	O
can	O
be	O
concluded	O
that	O
high	O
glucose	I:C0860803
could	O
elevate	O
NOXs	O
activity	I:C1151146
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
in	O
neural	O
tissues	I:C0027757
and	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
NOX	O
inhibitor	I:C1254351
drug	I:C1254351
may	O
prevent	O
and	O
delay	O
diabetic	B:C0342257
complications	I:C0342257
,	O
particularly	O
neuropathy	O
.	O

It	O
can	O
be	O
concluded	O
that	O
high	O
glucose	I:C0860803
could	O
elevate	O
NOXs	O
activity	I:C1151146
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
and	O
malondialdehyde	O
levels	O
in	O
neural	O
tissues	I:C0027757
and	O
Atorvastatin	O
as	O
a	O
small	O
molecule	I:C1328819
NOX	O
inhibitor	I:C1254351
drug	I:C1254351
may	O
prevent	O
and	O
delay	O
diabetic	O
complications	I:C0342257
,	O
particularly	O
neuropathy	B:C0442874
.	O

